- Home
- Mutual Funds
- Bajaj Finserv Mutual Fund
- Bajaj Finserv Healthcare Fund Direct-idcw
Fund Overview of Bajaj Finserv Healthcare Fund Direct-idcw
-
₹300.5 CrAUM
-
₹10.53NAV
-
1.47%Expense Ratio
-
EquityFund Category
As on Fri May 08, 2026
Calculate your Returns
How much do you want to invest monthly?
₹
Minimum amount you can invest: ₹500
Maximum amount you can invest: ₹1,00,000
We have used a return rate of 15% for our calculations.
The total value of your investment
after 10 years will be
₹ 0.00
Returns of Bajaj Finserv Healthcare Fund Direct-idcw
| Tenure | Absolute(%) | Annualised(%) | Category Average(%) |
|---|---|---|---|
| 3 Months | 10.52% | NA | 6.12% |
| 6 Months | 5.12% | NA | 12.92% |
| 1 Year | 13.16% | 13.16% | 6.04% |
As on Fri May 08, 2026
Asset Allocation
equities
94.75%debt instruments
1.78%other assets or cash equivalents
3.47%Large Cap: 38.40%
Mid Cap: 23.61%
Small Cap: 37.99%
Other: 0.00%
Detailed Portfolio Analysis
As on Fri May 08, 2026
Invest Now
Bajaj Finserv Healthcare Fund Direct-idcw is one Equity mutual fund offered by Bajaj Finserv Mutual Fund. Launched on 27 Dec 2024, the fund aims Wealth creation over long term. To invest predominantly in equity and equity related instruments of pharma, healthcare and allied companies. It manages assets worth ₹300.5 crore as on Tue Mar 31, 2026. The expense ratio stands at 1.47%. Fund Manager Manager Education Fund Manager Manager Education Fund Manager Manager Education
About FundAbout Bajaj Finserv Healthcare Fund Direct-idcw
The portfolio allocation consists of 94.75% in equities, 1.78% in debt instruments, 3.47% in other assets or cash equivalents.Managed by Sorbh Gupta, it has delivered a return of 13.16% in the last year, a total return since inception of 3.40%.
Identifying an appropriate best sip investment has a key part for systematic investing.
Nimesh Chandan
Mr. Chandan is an MBA in Finance.
Siddharth Chaudhary
Mr. Chaudhary is a B.Com (H) and PGDM (Securities Markets).
Sorbh Gupta
Mr. Gupta is a B.Com, CA and CFA.
Fund Details
|
|
Top Performing Mutual Funds
View More
growth is based on 1-month returns of the funds & Top fund are based on 3Y Returns
More funds from Bajaj Finserv Mutual Fund
| Fund Names | AUM (Cr) | 1M | 3M | 6M | 1Yr | 3Yr |
|---|---|---|---|---|---|---|
|
Bajaj Finserv Healthcare Fund Direct-growth
|
₹300 | 12.19% | 10.52% | 5.12% | 13.16% | - |
|
Bajaj Finserv Healthcare Fund Regular-growth
|
₹300 | 12.04% | 10.07% | 4.26% | 11.29% | - |
|
Bajaj Finserv Healthcare Fund Regular-idcw
|
₹300 | 12.04% | 10.07% | 4.26% | 11.29% | - |
growth is based on 1-month returns of the fundsMutual Fund Calculator
I want to invest
Pro Tip
Financial experts suggest that a person should invest 10-15% of their monthly income for long-term financial growth
/Month
I want to invest for
Pro Tip
Financial experts suggest that individuals should ideally invest for a period of 5 to 10 years, or even longer, to maximize the benefits of compounding and navigate market fluctuations effectively
Years
- 1
- 2
- 3
- 4
- 6
- 7
- 8
- 9
- 11
- 12
- 13
- 14
- 16
- 17
- 18
- 19
- 21
- 22
- 23
- 24
- 26
- 27
- 28
- 29
- 31
- 32
- 33
- 34
- 36
- 37
- 38
- 39
- 40
Expected return
Pro Tip
Top 25% of investors consistently generate more than 12% return
% Annually
- 1
- 2
- 3
- 4
- 6
- 7
- 8
- 9
- 11
- 12
- 13
- 14
- 16
- 17
- 18
- 19
- 21
- 22
- 23
- 24
- 26
- 27
- 28
- 30
Total Investment
Wealth Gained
Total Wealth
I want to save
I want to invest for
Pro Tip
Financial experts suggest that individuals should ideally invest for a period of 5 to 10 years, or even longer, to maximize the benefits of compounding and navigate market fluctuations effectively
Years
- 1
- 2
- 3
- 4
- 6
- 7
- 8
- 9
- 11
- 12
- 13
- 14
- 16
- 17
- 18
- 19
- 21
- 22
- 23
- 24
- 26
- 27
- 28
- 29
- 31
- 32
- 33
- 34
- 36
- 37
- 38
- 39
- 40
Expected return
Pro Tip
Top 25% of investors consistently generate more than 12% return
% Annually
- 1
- 2
- 3
- 4
- 6
- 7
- 8
- 9
- 11
- 12
- 13
- 14
- 16
- 17
- 18
- 19
- 21
- 22
- 23
- 24
- 26
- 27
- 28
- 30
Total Investment
Wealth Gained
Monthly Investment
Top Mutual Funds
| Fund Names | AUM (Cr) | NAV | 3Yr | 5Yr | 10Yr |
|---|---|---|---|---|---|
| Nippon India Pharma Fund-growth |
₹7,898 | ₹537.83 | 23.67% | 13.51% | 14.97% |
| Nippon India Pharma Fund Direct-growth |
₹7,898 | ₹603.39 | 24.79% | 14.54% | 16.00% |
| Nippon India Pharma Fund-idcw |
₹7,898 | ₹116.14 | 23.67% | 13.51% | 14.97% |
| Nippon India Pharma Fund Direct-idcw |
₹7,898 | ₹165.14 | 24.79% | 14.54% | 16.00% |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund-growth |
₹6,293 | ₹41.50 | 28.51% | 16.46% | - |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct-growth |
₹6,293 | ₹45.01 | 29.60% | 17.49% | - |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund-idcw |
₹6,293 | ₹24.21 | 28.51% | 16.46% | - |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct-idcw |
₹6,293 | ₹27.18 | 29.60% | 17.49% | - |
| SBI Healthcare Opportunities Fund-growth |
₹4,064 | ₹455.80 | 26.16% | 15.84% | 12.77% |
| SBI Healthcare Opportunities Fund Direct Plan-growth |
₹4,064 | ₹526.21 | 27.48% | 17.07% | 14.01% |
View More
Top funds are based on Fund AUM
Detailed Portfolio
| Stocks | Sector | % of Holding | Value |
|---|---|---|---|
| Divi's Laboratories Ltd | Healthcare | 8.81% | ₹29.60 Cr |
| Divi's Laboratories Ltd | Healthcare | 8.81% | ₹29.60 Cr |
| Divi's Laboratories Ltd | Healthcare | 9.21% | ₹28.98 Cr |
| Divi's Laboratories Ltd | Healthcare | 8.85% | ₹28.91 Cr |
| Divi's Laboratories Ltd | Healthcare | 8.41% | ₹28.46 Cr |
| Sun Pharmaceutical Industries Ltd | Healthcare | 9.41% | ₹28.26 Cr |
| Sun Pharmaceutical Industries Ltd | Healthcare | 8.24% | ₹27.88 Cr |
| Divi's Laboratories Ltd | Healthcare | 8.90% | ₹27.37 Cr |
| Divi's Laboratories Ltd | Healthcare | 7.94% | ₹27.09 Cr |
| Divi's Laboratories Ltd | Healthcare | 8.95% | ₹26.90 Cr |
| Sun Pharmaceutical Industries Ltd | Healthcare | 8.40% | ₹26.44 Cr |
| Sun Pharmaceutical Industries Ltd | Healthcare | 8.01% | ₹26.18 Cr |
| Sun Pharmaceutical Industries Ltd | Healthcare | 7.66% | ₹25.74 Cr |
| Sun Pharmaceutical Industries Ltd | Healthcare | 7.66% | ₹25.74 Cr |
| Sun Pharmaceutical Industries Ltd | Healthcare | 7.48% | ₹25.54 Cr |
| Divi's Laboratories Ltd | Healthcare | 7.75% | ₹25.00 Cr |
| Divi's Laboratories Ltd | Healthcare | 7.75% | ₹25.00 Cr |
| Sun Pharmaceutical Industries Ltd | Healthcare | 7.90% | ₹24.29 Cr |
| Sun Pharmaceutical Industries Ltd | Healthcare | 7.53% | ₹24.27 Cr |
| Sun Pharmaceutical Industries Ltd | Healthcare | 7.53% | ₹24.27 Cr |
| Apollo Hospitals Enterprise Ltd | Healthcare | 6.80% | ₹21.40 Cr |
| Apollo Hospitals Enterprise Ltd | Healthcare | 6.26% | ₹21.01 Cr |
| Apollo Hospitals Enterprise Ltd | Healthcare | 6.26% | ₹21.01 Cr |
| Apollo Hospitals Enterprise Ltd | Healthcare | 6.01% | ₹20.51 Cr |
| Apollo Hospitals Enterprise Ltd | Healthcare | 6.75% | ₹20.29 Cr |
| Apollo Hospitals Enterprise Ltd | Healthcare | 6.29% | ₹20.27 Cr |
| Apollo Hospitals Enterprise Ltd | Healthcare | 6.29% | ₹20.27 Cr |
| Apollo Hospitals Enterprise Ltd | Healthcare | 5.93% | ₹20.07 Cr |
| Aurobindo Pharma Ltd | Healthcare | 6.63% | ₹19.93 Cr |
| Piramal Pharma Ltd | Healthcare | 6.21% | ₹19.55 Cr |
| Apollo Hospitals Enterprise Ltd | Healthcare | 5.90% | ₹19.26 Cr |
| Apollo Hospitals Enterprise Ltd | Healthcare | 6.20% | ₹19.04 Cr |
| Aurobindo Pharma Ltd | Healthcare | 5.54% | ₹18.75 Cr |
| Aurobindo Pharma Ltd | Healthcare | 5.93% | ₹18.65 Cr |
| Aurobindo Pharma Ltd | Healthcare | 6.01% | ₹18.46 Cr |
| Cipla Ltd | Healthcare | 5.32% | ₹18.16 Cr |
| Aurobindo Pharma Ltd | Healthcare | 5.53% | ₹18.08 Cr |
| Cipla Ltd | Healthcare | 5.45% | ₹17.56 Cr |
| Cipla Ltd | Healthcare | 5.45% | ₹17.56 Cr |
| Torrent Pharmaceuticals Ltd | Healthcare | 5.46% | ₹17.17 Cr |
| Cipla Ltd | Healthcare | 5.06% | ₹17.14 Cr |
| Piramal Pharma Ltd | Healthcare | 5.69% | ₹17.10 Cr |
| Cipla Ltd | Healthcare | 5.18% | ₹16.91 Cr |
| Cipla Ltd | Healthcare | 5.00% | ₹16.80 Cr |
| Cipla Ltd | Healthcare | 5.00% | ₹16.80 Cr |
| Torrent Pharmaceuticals Ltd | Healthcare | 5.57% | ₹16.72 Cr |
| Piramal Pharma Ltd | Healthcare | 4.40% | ₹14.89 Cr |
| Others Cblo | Unspecified | 4.38% | ₹14.71 Cr |
| Others Cblo | Unspecified | 4.38% | ₹14.71 Cr |
| Others Cblo | Unspecified | 4.34% | ₹14.70 Cr |
| Neuland Laboratories Ltd | Healthcare | 4.26% | ₹14.42 Cr |
| Max Healthcare Institute Ltd | Healthcare | 4.40% | ₹13.85 Cr |
| Neuland Laboratories Ltd | Healthcare | 4.09% | ₹13.74 Cr |
| Neuland Laboratories Ltd | Healthcare | 4.09% | ₹13.74 Cr |
| Piramal Pharma Ltd | Healthcare | 4.19% | ₹13.70 Cr |
| Biocon Ltd | Healthcare | 4.00% | ₹13.53 Cr |
| Emcure Pharmaceuticals Ltd. | Healthcare | 4.35% | ₹13.08 Cr |
| Biocon Ltd | Healthcare | 3.76% | ₹12.82 Cr |
| Neuland Laboratories Ltd | Healthcare | 3.87% | ₹12.65 Cr |
| Biocon Ltd | Healthcare | 3.76% | ₹12.64 Cr |
| Biocon Ltd | Healthcare | 3.76% | ₹12.64 Cr |
| Fortis Healthcare Ltd | Healthcare | 3.83% | ₹12.36 Cr |
| Fortis Healthcare Ltd | Healthcare | 3.83% | ₹12.36 Cr |
| Piramal Pharma Ltd | Healthcare | 4.00% | ₹12.30 Cr |
| Fortis Healthcare Ltd | Healthcare | 3.66% | ₹12.30 Cr |
| Fortis Healthcare Ltd | Healthcare | 3.66% | ₹12.30 Cr |
| Max Healthcare Institute Ltd | Healthcare | 4.06% | ₹12.21 Cr |
| Neuland Laboratories Ltd | Healthcare | 3.78% | ₹12.18 Cr |
| Neuland Laboratories Ltd | Healthcare | 3.78% | ₹12.18 Cr |
| Emcure Pharmaceuticals Ltd. | Healthcare | 3.91% | ₹12.00 Cr |
| Emcure Pharmaceuticals Ltd. | Healthcare | 3.79% | ₹11.94 Cr |
| Glenmark Pharmaceuticals Ltd | Healthcare | 3.45% | ₹11.76 Cr |
| Aurobindo Pharma Limited November 2025 Future | Healthcare | 3.48% | ₹11.68 Cr |
| Aurobindo Pharma Limited November 2025 Future | Healthcare | 3.48% | ₹11.68 Cr |
| Rubicon Research Ltd. | 3.70% | ₹11.66 Cr | |
| Emcure Pharmaceuticals Ltd. | Healthcare | 3.43% | ₹11.60 Cr |
| Biocon Ltd | Healthcare | 3.59% | ₹11.58 Cr |
| Biocon Ltd | Healthcare | 3.59% | ₹11.58 Cr |
| Emcure Pharmaceuticals Ltd. | Healthcare | 3.39% | ₹11.56 Cr |
| Rubicon Research Ltd. | 3.84% | ₹11.55 Cr | |
| Dr. Reddy's Laboratories Ltd | Healthcare | 3.37% | ₹11.49 Cr |
| Cipla Ltd | Healthcare | 3.72% | ₹11.44 Cr |
| Fortis Healthcare Ltd | Healthcare | 3.60% | ₹11.33 Cr |
| Emcure Pharmaceuticals Ltd. | Healthcare | 3.42% | ₹11.19 Cr |
| Aurobindo Pharma Limited October 2025 Future | Healthcare | 3.44% | ₹11.08 Cr |
| Aurobindo Pharma Limited October 2025 Future | Healthcare | 3.44% | ₹11.08 Cr |
| Syngene International Ltd | Healthcare | 3.25% | ₹11.08 Cr |
| Dr. Reddy's Laboratories Ltd | Healthcare | 3.43% | ₹11.07 Cr |
| Dr. Reddy's Laboratories Ltd | Healthcare | 3.43% | ₹11.07 Cr |
| Neuland Laboratories Ltd | Healthcare | 3.60% | ₹11.05 Cr |
| Fortis Healthcare Ltd | Healthcare | 3.26% | ₹11.05 Cr |
| Fortis Healthcare Ltd | Healthcare | 3.20% | ₹10.92 Cr |
| Piramal Pharma Ltd | Healthcare | 3.24% | ₹10.89 Cr |
| Piramal Pharma Ltd | Healthcare | 3.24% | ₹10.89 Cr |
| Emcure Pharmaceuticals Ltd. | Healthcare | 3.22% | ₹10.82 Cr |
| Emcure Pharmaceuticals Ltd. | Healthcare | 3.22% | ₹10.82 Cr |
| Piramal Pharma Ltd | Healthcare | 3.15% | ₹10.74 Cr |
| Neuland Laboratories Ltd | Healthcare | 3.40% | ₹10.69 Cr |
| Aurobindo Pharma Ltd | Healthcare | 3.18% | ₹10.67 Cr |
| Aurobindo Pharma Ltd | Healthcare | 3.18% | ₹10.67 Cr |
| Fortis Healthcare Ltd | Healthcare | 3.25% | ₹10.62 Cr |
| Net Receivables | Unspecified | 3.08% | ₹10.59 Cr |
| Dr. Lal Pathlabs Ltd | Healthcare | 3.09% | ₹10.54 Cr |
| Net Receivables | Unspecified | 3.52% | ₹10.50 Cr |
| Emcure Pharmaceuticals Ltd. | Healthcare | 3.26% | ₹10.50 Cr |
| Emcure Pharmaceuticals Ltd. | Healthcare | 3.26% | ₹10.50 Cr |
| Dr. Lal Pathlabs Ltd | Healthcare | 3.24% | ₹10.43 Cr |
| Dr. Lal Pathlabs Ltd | Healthcare | 3.24% | ₹10.43 Cr |
| Piramal Pharma Ltd | Healthcare | 3.23% | ₹10.42 Cr |
| Piramal Pharma Ltd | Healthcare | 3.23% | ₹10.42 Cr |
| Neuland Laboratories Ltd | Healthcare | 3.42% | ₹10.27 Cr |
| Neuland Laboratories Ltd | Healthcare | 3.00% | ₹10.24 Cr |
| Fortis Healthcare Ltd | Healthcare | 3.33% | ₹10.23 Cr |
| Rubicon Research Ltd. | 3.33% | ₹10.22 Cr | |
| Rubicon Research Ltd. | 3.11% | ₹10.17 Cr | |
| Aurobindo Pharma Ltd | Healthcare | 3.15% | ₹10.16 Cr |
| Aurobindo Pharma Ltd | Healthcare | 3.15% | ₹10.16 Cr |
| Net Receivables | Unspecified | 3.22% | ₹10.00 Cr |
| Aurobindo Pharma Ltd | Healthcare | 2.89% | ₹9.88 Cr |
| Max Healthcare Institute Limited January 2026 Future | Healthcare | 2.95% | ₹9.65 Cr |
| Others Cblo | Unspecified | 2.97% | ₹9.58 Cr |
| Others Cblo | Unspecified | 2.97% | ₹9.58 Cr |
| Glenmark Pharmaceuticals Ltd | Healthcare | 2.97% | ₹9.56 Cr |
| Glenmark Pharmaceuticals Ltd | Healthcare | 2.97% | ₹9.56 Cr |
| Fortis Healthcare Ltd | Healthcare | 3.18% | ₹9.55 Cr |
| Glenmark Pharmaceuticals Ltd | Healthcare | 2.73% | ₹8.92 Cr |
| Max Healthcare Institute Limited February 2026 Future | Healthcare | 2.87% | ₹8.83 Cr |
| Glenmark Pharmaceuticals Ltd | Healthcare | 2.87% | ₹8.83 Cr |
| Dr. Lal Pathlabs Ltd | Healthcare | 2.61% | ₹8.77 Cr |
| Dr. Lal Pathlabs Ltd | Healthcare | 2.61% | ₹8.77 Cr |
| Others Cblo | Unspecified | 2.66% | ₹8.69 Cr |
| Pfizer Ltd | Healthcare | 2.48% | ₹8.48 Cr |
| Rubicon Research Ltd. | 2.47% | ₹8.37 Cr | |
| Lupin Ltd | Healthcare | 2.65% | ₹8.35 Cr |
| Torrent Pharmaceuticals Ltd | Healthcare | 2.42% | ₹8.26 Cr |
| Pfizer Ltd | Healthcare | 2.55% | ₹8.22 Cr |
| Pfizer Ltd | Healthcare | 2.55% | ₹8.22 Cr |
| Ipca Laboratories Ltd | Healthcare | 2.69% | ₹8.08 Cr |
| Rubicon Research Ltd. | 2.35% | ₹7.89 Cr | |
| Rubicon Research Ltd. | 2.35% | ₹7.89 Cr | |
| Lupin Ltd | Healthcare | 2.54% | ₹7.81 Cr |
| Ipca Laboratories Ltd | Healthcare | 2.45% | ₹7.72 Cr |
| Lupin Ltd | Healthcare | 2.34% | ₹7.65 Cr |
| Lupin Ltd | Healthcare | 2.23% | ₹7.55 Cr |
| Biocon Ltd | Healthcare | 2.29% | ₹7.47 Cr |
| Ipca Laboratories Ltd | Healthcare | 2.18% | ₹7.44 Cr |
| Ipca Laboratories Ltd | Healthcare | 2.42% | ₹7.43 Cr |
| Zydus Wellness Ltd | Consumer Staples | 2.46% | ₹7.40 Cr |
| Ipca Laboratories Ltd | Healthcare | 2.17% | ₹7.34 Cr |
| Aurobindo Pharma Limited December 2025 Future | Healthcare | 2.14% | ₹7.24 Cr |
| Ipca Laboratories Ltd | Healthcare | 2.19% | ₹7.16 Cr |
| Lupin Ltd | Healthcare | 2.12% | ₹7.12 Cr |
| Lupin Ltd | Healthcare | 2.12% | ₹7.12 Cr |
| Lupin Ltd | Healthcare | 2.05% | ₹7.00 Cr |
| Biocon Ltd | Healthcare | 2.26% | ₹6.95 Cr |
| Glenmark Pharmaceuticals Ltd | Healthcare | 2.05% | ₹6.94 Cr |
| Pfizer Ltd | Healthcare | 2.06% | ₹6.94 Cr |
| Pfizer Ltd | Healthcare | 2.06% | ₹6.94 Cr |
| Lupin Ltd | Healthcare | 2.15% | ₹6.93 Cr |
| Lupin Ltd | Healthcare | 2.15% | ₹6.93 Cr |
| Ipca Laboratories Ltd | Healthcare | 2.10% | ₹6.76 Cr |
| Ipca Laboratories Ltd | Healthcare | 2.10% | ₹6.76 Cr |
| Glenmark Pharmaceuticals Ltd | Healthcare | 2.01% | ₹6.74 Cr |
| Glenmark Pharmaceuticals Ltd | Healthcare | 2.01% | ₹6.74 Cr |
| Sanofi Consumer Healthcare India Ltd | Healthcare | 2.00% | ₹6.71 Cr |
| Sanofi Consumer Healthcare India Ltd | Healthcare | 2.00% | ₹6.71 Cr |
| Zydus Wellness Ltd | Consumer Staples | 2.17% | ₹6.66 Cr |
| Pfizer Ltd | Healthcare | 2.03% | ₹6.64 Cr |
| Vijaya Diagnostic Centre Ltd | Healthcare | 1.94% | ₹6.63 Cr |
| Pfizer Ltd | Healthcare | 1.96% | ₹6.62 Cr |
| Zydus Wellness Ltd | Consumer Staples | 1.96% | ₹6.57 Cr |
| Zydus Wellness Ltd | Consumer Staples | 1.96% | ₹6.57 Cr |
| Vijaya Diagnostic Centre Ltd | Healthcare | 2.00% | ₹6.55 Cr |
| Sanofi Consumer Healthcare India Ltd | Healthcare | 2.03% | ₹6.54 Cr |
| Sanofi Consumer Healthcare India Ltd | Healthcare | 2.03% | ₹6.54 Cr |
| Zomato Ltd | Technology | 1.99% | ₹6.51 Cr |
| Sanofi Consumer Healthcare India Ltd | Healthcare | 1.91% | ₹6.46 Cr |
| Shaily Engineering Plastics Ltd | Materials | 1.91% | ₹6.46 Cr |
| Ipca Laboratories Ltd | Healthcare | 1.91% | ₹6.42 Cr |
| Ipca Laboratories Ltd | Healthcare | 1.91% | ₹6.42 Cr |
| Zomato Ltd | Technology | 2.09% | ₹6.41 Cr |
| Glaxosmithkline Pharmaceuticals Ltd | Healthcare | 1.86% | ₹6.34 Cr |
| Zydus Wellness Ltd | Consumer Staples | 1.96% | ₹6.31 Cr |
| Zydus Wellness Ltd | Consumer Staples | 1.96% | ₹6.31 Cr |
| Godrej Consumer Products Ltd | Consumer Staples | 1.84% | ₹6.30 Cr |
| Zydus Wellness Ltd | Consumer Staples | 2.00% | ₹6.29 Cr |
| Zydus Wellness Ltd | Consumer Staples | 1.92% | ₹6.27 Cr |
| Sanofi Consumer Healthcare India Ltd | Healthcare | 1.92% | ₹6.27 Cr |
| Navin Fluorine International Ltd | Materials | 1.99% | ₹6.26 Cr |
| Sanofi Consumer Healthcare India Ltd | Healthcare | 1.98% | ₹6.22 Cr |
| Sanofi Consumer Healthcare India Ltd | Healthcare | 1.82% | ₹6.22 Cr |
| Vijaya Diagnostic Centre Ltd | Healthcare | 1.97% | ₹6.20 Cr |
| Vijaya Diagnostic Centre Ltd | Healthcare | 1.91% | ₹6.17 Cr |
| Vijaya Diagnostic Centre Ltd | Healthcare | 1.91% | ₹6.17 Cr |
| Navin Fluorine International Ltd | Materials | 2.05% | ₹6.16 Cr |
| Vijaya Diagnostic Centre Ltd | Healthcare | 1.82% | ₹6.16 Cr |
| Glaxosmithkline Pharmaceuticals Ltd | Healthcare | 1.94% | ₹6.12 Cr |
| Godrej Consumer Products Ltd | Consumer Staples | 1.87% | ₹6.11 Cr |
| Vijaya Diagnostic Centre Ltd | Healthcare | 1.82% | ₹6.10 Cr |
| Vijaya Diagnostic Centre Ltd | Healthcare | 1.82% | ₹6.10 Cr |
| Godrej Consumer Products Ltd | Consumer Staples | 1.93% | ₹6.09 Cr |
| Pfizer Ltd | Healthcare | 1.98% | ₹6.08 Cr |
| Dr. Reddy's Laboratories Ltd | Healthcare | 1.79% | ₹6.02 Cr |
| Dr. Reddy's Laboratories Ltd | Healthcare | 1.79% | ₹6.02 Cr |
| Eternal Limited-feb2026 | Technology | 1.95% | ₹5.99 Cr |
| Abbott India Ltd | Healthcare | 1.75% | ₹5.98 Cr |
| Sanofi Consumer Healthcare India Ltd | Healthcare | 1.98% | ₹5.96 Cr |
| Zydus Wellness Ltd | Consumer Staples | 1.75% | ₹5.94 Cr |
| Glenmark Pharmaceuticals Ltd | Healthcare | 1.88% | ₹5.93 Cr |
| Vijaya Diagnostic Centre Ltd | Healthcare | 1.93% | ₹5.92 Cr |
| Glenmark Pharmaceuticals Ltd | Healthcare | 1.97% | ₹5.91 Cr |
| Sanofi Consumer Healthcare India Ltd | Healthcare | 1.92% | ₹5.89 Cr |
| Glaxosmithkline Pharmaceuticals Ltd | Healthcare | 1.80% | ₹5.89 Cr |
| Godrej Consumer Products Ltd | Consumer Staples | 1.81% | ₹5.83 Cr |
| Godrej Consumer Products Ltd | Consumer Staples | 1.81% | ₹5.83 Cr |
| Godrej Consumer Products Ltd | Consumer Staples | 1.88% | ₹5.77 Cr |
| Godrej Consumer Products Ltd | Consumer Staples | 1.69% | ₹5.73 Cr |
| Medi Assist Healthcare Services Ltd. | Industrials | 1.71% | ₹5.73 Cr |
| Medi Assist Healthcare Services Ltd. | Industrials | 1.71% | ₹5.73 Cr |
| Glaxosmithkline Pharmaceuticals Ltd | Healthcare | 1.86% | ₹5.71 Cr |
| Shaily Engineering Plastics Ltd | Materials | 1.68% | ₹5.64 Cr |
| Shaily Engineering Plastics Ltd | Materials | 1.68% | ₹5.64 Cr |
| Shaily Engineering Plastics Ltd | Materials | 1.72% | ₹5.61 Cr |
| Zydus Wellness Ltd | Consumer Staples | 1.64% | ₹5.60 Cr |
| Godrej Consumer Products Ltd | Consumer Staples | 1.67% | ₹5.59 Cr |
| Godrej Consumer Products Ltd | Consumer Staples | 1.67% | ₹5.59 Cr |
| Glaxosmithkline Pharmaceuticals Ltd | Healthcare | 1.73% | ₹5.57 Cr |
| Glaxosmithkline Pharmaceuticals Ltd | Healthcare | 1.73% | ₹5.57 Cr |
| Glaxosmithkline Pharmaceuticals Ltd | Healthcare | 1.63% | ₹5.49 Cr |
| Glaxosmithkline Pharmaceuticals Ltd | Healthcare | 1.63% | ₹5.49 Cr |
| Hindustan Unilever Ltd | Consumer Staples | 1.60% | ₹5.46 Cr |
| Glaxosmithkline Pharmaceuticals Ltd | Healthcare | 1.81% | ₹5.43 Cr |
| Shaily Engineering Plastics Ltd | Materials | 1.68% | ₹5.40 Cr |
| Shaily Engineering Plastics Ltd | Materials | 1.68% | ₹5.40 Cr |
| Glaxosmithkline Pharmaceuticals Ltd | Healthcare | 1.59% | ₹5.38 Cr |
| Dr. Lal Pathlabs Ltd | Healthcare | 1.59% | ₹5.38 Cr |
| Medi Assist Healthcare Services Ltd. | Industrials | 1.57% | ₹5.36 Cr |
| Vijaya Diagnostic Centre Ltd | Healthcare | 1.77% | ₹5.32 Cr |
| Medi Assist Healthcare Services Ltd. | Industrials | 1.63% | ₹5.25 Cr |
| Medi Assist Healthcare Services Ltd. | Industrials | 1.63% | ₹5.25 Cr |
| Abbott India Ltd | Healthcare | 1.54% | ₹5.23 Cr |
| Dr. Lal Pathlabs Ltd | Healthcare | 1.60% | ₹5.22 Cr |
| Alkem Laboratories Ltd | Healthcare | 1.61% | ₹5.18 Cr |
| Alkem Laboratories Ltd | Healthcare | 1.61% | ₹5.18 Cr |
| Shaily Engineering Plastics Ltd | Materials | 1.72% | ₹5.17 Cr |
| Bajaj Finserv Money Market Fund Direct-growth | Unspecified | 1.71% | ₹5.13 Cr |
| Bajaj Finserv Money Market Fund Direct-growth | Unspecified | 1.62% | ₹5.11 Cr |
| Abbott India Ltd | Healthcare | 1.58% | ₹5.09 Cr |
| Abbott India Ltd | Healthcare | 1.58% | ₹5.09 Cr |
| Bajaj Finserv Money Market Fund Direct-growth | Unspecified | 1.65% | ₹5.08 Cr |
| Bajaj Finserv Money Market Fund Direct-growth | Unspecified | 1.55% | ₹5.06 Cr |
| Abbott India Ltd | Healthcare | 1.54% | ₹5.04 Cr |
| Abbott India Ltd | Healthcare | 1.50% | ₹5.04 Cr |
| Abbott India Ltd | Healthcare | 1.50% | ₹5.04 Cr |
| Bajaj Finserv Money Market Fund Direct-growth | Unspecified | 1.49% | ₹5.04 Cr |
| Bajaj Finserv Money Market Fund Direct-growth | Unspecified | 1.49% | ₹5.01 Cr |
| Bajaj Finserv Money Market Fund Direct-growth | Unspecified | 1.49% | ₹5.01 Cr |
| Dr. Lal Pathlabs Ltd | Healthcare | 1.62% | ₹4.97 Cr |
| Laurus Labs Ltd | Healthcare | 1.65% | ₹4.96 Cr |
| Dr. Lal Pathlabs Ltd | Healthcare | 1.57% | ₹4.93 Cr |
| Godrej Consumer Products Ltd | Consumer Staples | 1.64% | ₹4.92 Cr |
| Shaily Engineering Plastics Ltd | Materials | 1.54% | ₹4.84 Cr |
| Alkem Laboratories Ltd | Healthcare | 1.41% | ₹4.81 Cr |
| Medplus Health Services Ltd | Healthcare | 1.41% | ₹4.81 Cr |
| Abbott India Ltd | Healthcare | 1.56% | ₹4.79 Cr |
| Medi Assist Healthcare Services Ltd. | Industrials | 1.41% | ₹4.78 Cr |
| Shaily Engineering Plastics Ltd | Materials | 1.54% | ₹4.75 Cr |
| Lupin Ltd | Healthcare | 1.56% | ₹4.69 Cr |
| Dr. Lal Pathlabs Ltd | Healthcare | 1.54% | ₹4.62 Cr |
| Medi Assist Healthcare Services Ltd. | Industrials | 1.41% | ₹4.62 Cr |
| Abbott India Ltd | Healthcare | 1.46% | ₹4.61 Cr |
| Torrent Pharmaceuticals Ltd | Healthcare | 1.42% | ₹4.57 Cr |
| Torrent Pharmaceuticals Ltd | Healthcare | 1.42% | ₹4.57 Cr |
| Emami Ltd | Consumer Staples | 1.33% | ₹4.53 Cr |
| Alkem Laboratories Ltd | Healthcare | 1.34% | ₹4.51 Cr |
| Alkem Laboratories Ltd | Healthcare | 1.34% | ₹4.51 Cr |
| Abbott India Ltd | Healthcare | 1.50% | ₹4.50 Cr |
| Rainbow Childrens Medicare Ltd | Healthcare | 1.32% | ₹4.50 Cr |
| Biocon Ltd | Healthcare | 1.42% | ₹4.47 Cr |
| Medplus Health Services Ltd | Healthcare | 1.39% | ₹4.38 Cr |
| Max Healthcare Institute Ltd | Healthcare | 1.28% | ₹4.36 Cr |
| Medplus Health Services Ltd | Healthcare | 1.44% | ₹4.34 Cr |
| Jubilant Pharmova Ltd | Healthcare | 1.22% | ₹4.18 Cr |
| Medplus Health Services Ltd | Healthcare | 1.23% | ₹4.18 Cr |
| Medplus Health Services Ltd | Healthcare | 1.28% | ₹4.17 Cr |
| Biocon Ltd | Healthcare | 1.38% | ₹4.13 Cr |
| Medplus Health Services Ltd | Healthcare | 1.34% | ₹4.13 Cr |
| Torrent Pharmaceuticals Ltd | Healthcare | 1.33% | ₹4.09 Cr |
| Max Healthcare Institute Ltd | Healthcare | 1.20% | ₹4.07 Cr |
| Rainbow Childrens Medicare Ltd | Healthcare | 1.20% | ₹4.04 Cr |
| Rainbow Childrens Medicare Ltd | Healthcare | 1.20% | ₹4.04 Cr |
| Max Healthcare Institute Ltd | Healthcare | 1.20% | ₹4.02 Cr |
| Max Healthcare Institute Ltd | Healthcare | 1.20% | ₹4.02 Cr |
| Medi Assist Healthcare Services Ltd. | Industrials | 1.31% | ₹4.01 Cr |
| Rainbow Childrens Medicare Ltd | Healthcare | 1.24% | ₹4.00 Cr |
| Rainbow Childrens Medicare Ltd | Healthcare | 1.24% | ₹4.00 Cr |
| Rainbow Childrens Medicare Ltd | Healthcare | 1.18% | ₹3.99 Cr |
| Torrent Pharmaceuticals Ltd | Healthcare | 1.22% | ₹3.98 Cr |
| Medplus Health Services Ltd | Healthcare | 1.17% | ₹3.94 Cr |
| Medplus Health Services Ltd | Healthcare | 1.17% | ₹3.94 Cr |
| Shaily Engineering Plastics Ltd | Materials | 1.15% | ₹3.94 Cr |
| Hindustan Unilever Ltd | Consumer Staples | 1.22% | ₹3.92 Cr |
| Hindustan Unilever Ltd | Consumer Staples | 1.22% | ₹3.92 Cr |
| Medplus Health Services Ltd | Healthcare | 1.21% | ₹3.91 Cr |
| Medplus Health Services Ltd | Healthcare | 1.21% | ₹3.91 Cr |
| Alembic Pharmaceuticals Ltd | Healthcare | 1.14% | ₹3.91 Cr |
| Max Healthcare Institute Ltd | Healthcare | 1.21% | ₹3.90 Cr |
| Max Healthcare Institute Ltd | Healthcare | 1.21% | ₹3.90 Cr |
| Rainbow Childrens Medicare Ltd | Healthcare | 1.19% | ₹3.89 Cr |
| Jubilant Pharmova Ltd | Healthcare | 1.15% | ₹3.85 Cr |
| Jubilant Pharmova Ltd | Healthcare | 1.15% | ₹3.85 Cr |
| Hindustan Unilever Ltd | Consumer Staples | 1.14% | ₹3.84 Cr |
| Torrent Pharmaceuticals Ltd | Healthcare | 1.13% | ₹3.84 Cr |
| Hindustan Unilever Ltd | Consumer Staples | 1.14% | ₹3.84 Cr |
| Hindustan Unilever Ltd | Consumer Staples | 1.14% | ₹3.84 Cr |
| Jubilant Pharmova Ltd | Healthcare | 1.13% | ₹3.81 Cr |
| Jubilant Pharmova Ltd | Healthcare | 1.17% | ₹3.78 Cr |
| Jubilant Pharmova Ltd | Healthcare | 1.17% | ₹3.78 Cr |
| Jubilant Pharmova Ltd | Healthcare | 1.15% | ₹3.76 Cr |
| Mankind Pharma Ltd. | Healthcare | 1.09% | ₹3.73 Cr |
| Medi Assist Healthcare Services Ltd. | Industrials | 1.18% | ₹3.73 Cr |
| Krishna Institute Of Medical Sciences Ltd | Healthcare | 1.18% | ₹3.73 Cr |
| Hindustan Unilever Ltd | Consumer Staples | 1.20% | ₹3.70 Cr |
| Torrent Pharmaceuticals Ltd | Healthcare | 1.09% | ₹3.68 Cr |
| Torrent Pharmaceuticals Ltd | Healthcare | 1.09% | ₹3.68 Cr |
| Max Healthcare Institute Ltd | Healthcare | 1.12% | ₹3.66 Cr |
| Hindustan Unilever Ltd | Consumer Staples | 1.16% | ₹3.64 Cr |
| Alembic Pharmaceuticals Ltd | Healthcare | 1.07% | ₹3.62 Cr |
| Hindustan Unilever Ltd | Consumer Staples | 1.10% | ₹3.61 Cr |
| Alembic Pharmaceuticals Ltd | Healthcare | 1.12% | ₹3.60 Cr |
| Alembic Pharmaceuticals Ltd | Healthcare | 1.12% | ₹3.60 Cr |
| Syngene International Ltd | Healthcare | 1.10% | ₹3.59 Cr |
| Alembic Pharmaceuticals Ltd | Healthcare | 1.07% | ₹3.58 Cr |
| Alembic Pharmaceuticals Ltd | Healthcare | 1.07% | ₹3.58 Cr |
| Syngene International Ltd | Healthcare | 1.07% | ₹3.58 Cr |
| Syngene International Ltd | Healthcare | 1.07% | ₹3.58 Cr |
| Tata Consumer Products Ltd | Consumer Staples | 1.09% | ₹3.58 Cr |
| Syngene International Ltd | Healthcare | 1.06% | ₹3.57 Cr |
| Mankind Pharma Ltd. | Healthcare | 1.10% | ₹3.54 Cr |
| Mankind Pharma Ltd. | Healthcare | 1.10% | ₹3.54 Cr |
| Tata Consumer Products Ltd | Consumer Staples | 1.04% | ₹3.52 Cr |
| Mankind Pharma Ltd. | Healthcare | 1.03% | ₹3.46 Cr |
| Mankind Pharma Ltd. | Healthcare | 1.03% | ₹3.46 Cr |
| Emami Ltd | Consumer Staples | 1.02% | ₹3.44 Cr |
| Jubilant Pharmova Ltd | Healthcare | 1.12% | ₹3.44 Cr |
| Syngene International Ltd | Healthcare | 1.07% | ₹3.43 Cr |
| Syngene International Ltd | Healthcare | 1.07% | ₹3.43 Cr |
| Emami Ltd | Consumer Staples | 1.05% | ₹3.42 Cr |
| Tata Consumer Products Ltd | Consumer Staples | 1.09% | ₹3.42 Cr |
| Tata Consumer Products Ltd | Consumer Staples | 1.11% | ₹3.40 Cr |
| Eris Lifesciences Ltd | Healthcare | 1.08% | ₹3.40 Cr |
| Alembic Pharmaceuticals Ltd | Healthcare | 1.03% | ₹3.38 Cr |
| Rainbow Childrens Medicare Ltd | Healthcare | 1.09% | ₹3.36 Cr |
| Max Healthcare Institute Ltd | Healthcare | 1.09% | ₹3.35 Cr |
| Mankind Pharma Ltd. | Healthcare | 0.97% | ₹3.27 Cr |
| Eris Lifesciences Ltd | Healthcare | 1.08% | ₹3.24 Cr |
| Cipla Ltd | Healthcare | 1.02% | ₹3.20 Cr |
| Mankind Pharma Ltd. | Healthcare | 0.98% | ₹3.19 Cr |
| Emami Ltd | Consumer Staples | 1.02% | ₹3.13 Cr |
| Alembic Pharmaceuticals Ltd | Healthcare | 1.02% | ₹3.13 Cr |
| Astrazeneca Pharma India Ltd | Healthcare | 0.93% | ₹3.12 Cr |
| Astrazeneca Pharma India Ltd | Healthcare | 0.93% | ₹3.12 Cr |
| Krishna Institute Of Medical Sciences Ltd | Healthcare | 1.03% | ₹3.11 Cr |
| Jubilant Pharmova Ltd | Healthcare | 0.96% | ₹3.03 Cr |
| Astrazeneca Pharma India Ltd | Healthcare | 0.88% | ₹3.00 Cr |
| Emami Ltd | Consumer Staples | 0.95% | ₹3.00 Cr |
| Medi Assist Healthcare Services Ltd. | Industrials | 0.99% | ₹2.99 Cr |
| Astrazeneca Pharma India Ltd | Healthcare | 0.92% | ₹2.97 Cr |
| Astrazeneca Pharma India Ltd | Healthcare | 0.92% | ₹2.97 Cr |
| Emami Ltd | Consumer Staples | 0.92% | ₹2.96 Cr |
| Emami Ltd | Consumer Staples | 0.92% | ₹2.96 Cr |
| Astrazeneca Pharma India Ltd | Healthcare | 0.90% | ₹2.95 Cr |
| Astrazeneca Pharma India Ltd | Healthcare | 0.87% | ₹2.95 Cr |
| Emami Ltd | Consumer Staples | 0.88% | ₹2.94 Cr |
| Emami Ltd | Consumer Staples | 0.88% | ₹2.94 Cr |
| Astrazeneca Pharma India Ltd | Healthcare | 0.92% | ₹2.89 Cr |
| Jubilant Pharmova Ltd | Healthcare | 0.95% | ₹2.86 Cr |
| Alembic Pharmaceuticals Ltd | Healthcare | 0.90% | ₹2.84 Cr |
| Astrazeneca Pharma India Ltd | Healthcare | 0.91% | ₹2.79 Cr |
| Zomato Ltd | Technology | 0.78% | ₹2.63 Cr |
| Emami Ltd | Consumer Staples | 0.85% | ₹2.55 Cr |
| Astrazeneca Pharma India Ltd | Healthcare | 0.84% | ₹2.54 Cr |
| Marico Ltd | Consumer Staples | 0.73% | ₹2.37 Cr |
| Marico Ltd | Consumer Staples | 0.68% | ₹2.27 Cr |
| Marico Ltd | Consumer Staples | 0.68% | ₹2.27 Cr |
| Marico Ltd | Consumer Staples | 0.67% | ₹2.27 Cr |
| Others Cblo | Unspecified | 0.72% | ₹2.25 Cr |
| Marico Ltd | Consumer Staples | 0.66% | ₹2.24 Cr |
| Marico Ltd | Consumer Staples | 0.68% | ₹2.20 Cr |
| Marico Ltd | Consumer Staples | 0.68% | ₹2.20 Cr |
| Pb Fintech Ltd | Financial | 0.52% | ₹1.78 Cr |
| Pb Fintech Ltd | Financial | 0.52% | ₹1.67 Cr |
| Pb Fintech Ltd | Financial | 0.52% | ₹1.67 Cr |
| Nestle India Ltd | Consumer Staples | 0.50% | ₹1.60 Cr |
| Nestle India Ltd | Consumer Staples | 0.50% | ₹1.60 Cr |
| Nestle India Ltd | Consumer Staples | 0.46% | ₹1.56 Cr |
| Neogen Chemicals Ltd | Materials | 0.43% | ₹1.45 Cr |
| Neogen Chemicals Ltd | Materials | 0.44% | ₹1.42 Cr |
| Neogen Chemicals Ltd | Materials | 0.44% | ₹1.42 Cr |
| Neogen Chemicals Ltd | Materials | 0.41% | ₹1.36 Cr |
| Neogen Chemicals Ltd | Materials | 0.41% | ₹1.36 Cr |
| Suven Pharmaceuticals Ltd | Healthcare | 0.33% | ₹1.05 Cr |
| Suven Pharmaceuticals Ltd | Healthcare | 0.33% | ₹1.05 Cr |
| Suven Pharmaceuticals Ltd | Healthcare | 0.27% | ₹0.90 Cr |
| Suven Pharmaceuticals Ltd | Healthcare | 0.27% | ₹0.90 Cr |
| Others Cblo | Unspecified | 0.17% | ₹0.57 Cr |
| Net Receivables | Unspecified | 0.14% | ₹0.40 Cr |
| Others Cblo | Unspecified | 0.02% | ₹0.07 Cr |
| Others Cblo | Unspecified | 0.02% | ₹0.06 Cr |
| Kwality Walls India Ltd | 0.02% | ₹0.06 Cr | |
| Kwality Walls India Ltd | 0.02% | ₹0.06 Cr | |
| Kwality Walls India Ltd | 0.01% | ₹0.04 Cr | |
| Net Payables | Unspecified | -1.08% | ₹-3.51 Cr |
| Net Payables | Unspecified | -1.72% | ₹-5.39 Cr |
| Net Payables | Unspecified | -1.72% | ₹-5.39 Cr |
| Sun Pharmaceutical Industries Limited February 2026 Future | Healthcare | -1.81% | ₹-5.58 Cr |
| Net Payables | Unspecified | -1.68% | ₹-5.59 Cr |
| Net Payables | Unspecified | -1.68% | ₹-5.59 Cr |
| Net Payables | Unspecified | -1.78% | ₹-5.88 Cr |
View More
Top Equity Funds
| Fund Names | NAV | 3Yr | 5Yr | 52 weeks high |
|---|---|---|---|---|
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct-growth |
₹45.01 | 29.60% | 17.49% | - |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct-idcw |
₹27.18 | 29.60% | 17.49% | - |
| SBI Healthcare Opportunities Fund Direct Plan-growth |
₹526.21 | 27.48% | 17.07% | - |
| SBI Healthcare Opportunities Fund Direct Plan-idcw |
₹365.60 | 27.48% | 17.07% | - |
| Mirae Asset Healthcare Fund Direct-growth |
₹47.15 | 27.16% | 16.47% | - |
| Mirae Asset Healthcare Fund Direct-idcw |
₹28.40 | 27.16% | 16.47% | - |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund-growth |
₹41.50 | 28.51% | 16.46% | - |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund-idcw |
₹24.21 | 28.51% | 16.46% | - |
| SBI Healthcare Opportunities Fund-growth |
₹455.80 | 26.16% | 15.84% | - |
| SBI Healthcare Opportunities Fund-idcw |
₹287.13 | 26.16% | 15.84% | - |
View More
growth is based on 5Y returns of the funds
Frequently Asked Questions
Bajaj Finserv Healthcare Fund Direct-idcw
What is the current AUM of Bajaj Finserv Healthcare Fund Direct-idcw?
As of Tue Mar 31, 2026, Bajaj Finserv Healthcare Fund Direct-idcw manages assets worth ₹300.5 crore
How has Bajaj Finserv Healthcare Fund Direct-idcw performed recently?
- 3 Months: 10.52%
- 6 Months: 5.12%
What is the long-term performance of Bajaj Finserv Healthcare Fund Direct-idcw?
- Since Inception: 3.40%
What is the portfolio composition of Bajaj Finserv Healthcare Fund Direct-idcw?
Equity: 94.75%, Debt: 1.78%, Others: 3.47%.
Who manages Bajaj Finserv Healthcare Fund Direct-idcw?
Bajaj Finserv Healthcare Fund Direct-idcw is managed by Sorbh Gupta from Bajaj Finserv Mutual Fund.
What is the market-cap allocation of Bajaj Finserv Healthcare Fund Direct-idcw?
Large Cap: 38.40%, Mid Cap: 23.61%, Small Cap: 37.99%.
Which are the top companies Bajaj Finserv Healthcare Fund Direct-idcw has invested in?
- Divi's Laboratories Ltd – 8.81% of the fund's portfolio
- Divi's Laboratories Ltd – 8.81% of the fund's portfolio
- Divi's Laboratories Ltd – 9.21% of the fund's portfolio
- Divi's Laboratories Ltd – 8.85% of the fund's portfolio
- Divi's Laboratories Ltd – 8.41% of the fund's portfolio
Which are the major sectors Bajaj Finserv Healthcare Fund Direct-idcw focuses on?
- Healthcare – 830.58% of the fund's portfolio
- Consumer Staples – 68.90% of the fund's portfolio
- Unspecified – 33.93% of the fund's portfolio
- Materials – 22.47% of the fund's portfolio
- Other – 21.20% of the fund's portfolio
View more FAQ's
Policybazaar does not endorse rates/returns or recommend any particular insurer, fund house, AMC (Asset Management Company), insurance and mutual fund product.
Please consult your financial advisor for an informed decision.
Past performance may not be indicative of future results.
The information presented on this page is not owned or generated by Policybazaar. The data has been collected from publicly available sources and online research. We do not claim any ownership or guarantee the accuracy, completeness, or timeliness of this information. It is shared solely for the informational purpose of the viewer and should not be considered as financial advice.
Policybazaar is not acting as a financial advisor, broker, or agent for any mutual fund mentioned here.
Mutual fund investments are subject to market risks. Please read all scheme-related documents carefully before investing.
Policybazaar shall not be held responsible or liable for any losses, damages, or decisions made based on the information provided on this page.
For a complete list of mutual funds registered in India, please refer to the Securities and Exchange Board of India (SEBI) website at www.sebi.gov.in. We do not sell, endorse, or recommend any mutual fund or investment product. For a complete list of mutual funds registered in India, please refer to the Securities and Exchange Board of India (SEBI) website at www.sebi.gov.in. We do not sell, endorse, or recommend any mutual fund or investment product.
For more details on risk factors, terms, and conditions, please read the sales brochure and benefit illustration carefully before concluding a sale.
Policybazaar is a registered Insurance Broker | Registration No. 742, Registration Code No. IRDA/ DB 797/ 19, Valid till 09/06/2024, License category- Direct Broker (Life & General) |CIN: U74999HR2014PTC053454 | Registered Office - Plot No.119, Sector - 44, Gurgaon, Haryana – 122001 |Visitors are hereby informed that their information submitted on the website may be shared with insurers. Product information is authentic and solely based on the information received from the insurers.©️ Copyright 2008-2025 policybazaar.com. All Rights Reserved
^Returns as on 10th Jan’25. Tata AIA Life Top 200 ULIP Fund has delivered 18% returns over the last 10 years. Past performance is not necessarily indicative of future results. This disclaimer is specifically regarding a ULIP fund and is not related to mutual funds. Source: Morningstar.
